Court of Appeal, First District, Division 2, California. James CLAYWORTH, et al., Plaintiffs and Appellants, v. PFIZER, INC., et al., Defendants and Respondents.
Mostly it's the time element, to go over all possibilities of reactions, and there's other reactions ... Larkin v. Pfizer, Inc., No. 3:99CV-649-R, slip op. at 5, 2001 WL 34065029 (W.D.Ky. ..... the learned intermediary rule in the Product Liability Act, KRS 411.300, et seq., indicates a legislative ... Reed, Ky., 950 S.W.2d 811 (1997) .
Jul 12, 2010 ... v. Ct.App. 1/2 A116798 PFIZER, INC., et al., Alameda County ... Pharmacy and Clayworth Healthcare; Marin Apothecaries, Inc., dba Ross Valley ...... Reed Smith , Michael Diane Floyd, Kirsten J. Handelman; Oppenheimer ...
Apr 11, 2017 ... THE UNITED STATES OF AMERICA, et al.,. : ex rel. ... Presently before the Court is Defendant Pfizer Inc.'s Second Motion to Dismiss. (ECF. No.
Jan 28, 2015 ... ... securities laws, according to a Securities and Exchange Commission document filed by Pfizer yesterday (Mary K. Jones v. Pfizer Inc., et al., ...
... al. trial reasons (1993) 50 C.P.R. (3d) 1 (F.C.T.D. per Reed J.) trial judgment ( 1994) 54 C.P.R. (3d) 351 (F.C.T.D. per Reed J.) ... Amfac Foods Inc. et al v. ... Pfizer Canada Inc. (et al) 2009 FCA 8 (F.C.A. per Noel J.A., Letourneau and Blais JJ.
Jan 17, 2017 ... Ian Read, chairman and chief executive officer of Pfizer Inc., gestures as he ... Trump vs. big pharma 7:26 PM ET Wed, 11 Jan 2017 | 03:44.
Jan 30, 2018 ... CEO Ian Reed says Pfizer is on track to make a decision on its ... Published 6:53 AM ET Tue, 30 Jan 2018 Updated 7:59 AM ET Tue, 30 Jan 2018 ... EPS: 62 cents vs. the Thomson Reuters estimate of 56 cents. ... In the fourth quarter, the company reported a net profit of $12.3 billion, ... All Rights Reserved.
All decisions filed in the current term of the Supreme Court of Appeals of West Virginia. ... Pat Reed, Comm. W. Va. Div. of .... 05/25/2018, 14-1339, California State Teachers' Retirement et al. v. ... Pfizer, Inc, Roerig, a Division of Pfizer Inc., et al.